Weeks 4 to 8: Body Composition Begins Shifting The scale may not change significantly in this window, but body composition does
In summary, semaglutide has proven to be a pinnacle of GLP-1 drug development so far: highly efficacious for glycemic control, capable of inducing substantial weight loss, and demonstrating broad benefits (cardiovascular, renal, and beyond)
Therapeutic targets for treating fibrotic kidney diseases
Limiting carbohydrate intake is one critical step
Digestive upset such as bloating, nausea, or cramping Headaches as the body adjusts to increased detox support Rare allergic reactions like skin flushing or rash These tend to be temporary and improve with hydration, food pairing, or dose adjustments
The real appeal of metformin as a tirzepatide alternative lies in its cost (as low as $4-10 per month for generic), its extensive safety record spanning decades, and emerging research suggesting longevity benefits independent of blood sugar control